Precision Medicine Global Market Report 2026

Description

Precision medicine is a type of treatment that prevents, detects, or manages disease by using information about an individual's genes or proteins. It takes into account a person's genetics, environment, and lifestyle to select the therapy most likely to be effective.

The main technologies used in precision medicine include bioinformatics, big data analytics, drug discovery, gene sequencing, companion diagnostics, and others. Bioinformatics applies computational tools to organize, analyze, interpret, visualize, and store data related to biological macromolecules. Precision medicine is applied in areas such as oncology, respiratory diseases, central nervous system disorders, immunology, genetic diseases, and more, and is implemented across sectors including pharmaceuticals, diagnostic companies, healthcare providers, and IT firms.

Tariffs have influenced the precision medicine market by increasing costs and supply chain complexities for gene sequencing instruments, diagnostic reagents, and bioinformatics hardware sourced globally. Higher import duties have particularly affected drug discovery, companion diagnostics, and gene sequencing segments, with Asia-Pacific and Europe experiencing notable impacts due to cross-border dependency on specialized components. Oncology and genomic testing applications face cost pressures that may slow adoption in price-sensitive healthcare systems. However, tariffs are also encouraging localized manufacturing, regional partnerships, and domestic innovation, supporting long-term supply resilience and technology self-sufficiency in key markets.

The precision medicine market research report is one of a series of new reports from The Business Research Company that provides precision medicine market statistics, including precision medicine industry global market size, regional shares, competitors with a precision medicine market share, detailed precision medicine market segments, market trends and opportunities, and any further data you may need to thrive in the precision medicine industry. This precision medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The precision medicine market size has grown strongly in recent years. It will grow from $87.91 billion in 2025 to $96.27 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to advancements in genomic research, declining cost of gene sequencing, increasing prevalence of cancer and genetic disorders, growth in biopharmaceutical R&D spending, regulatory approvals for targeted therapies.

The precision medicine market size is expected to see strong growth in the next few years. It will grow to $137.69 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to expansion of next-generation sequencing adoption, rising demand for personalized treatment plans, growing use of ai-driven drug discovery, increasing investments in precision diagnostics, integration of digital health platforms. Major trends in the forecast period include rising adoption of companion diagnostics, shift toward personalized oncology therapies, integration of multi-omics data in clinical decision-making, expansion of precision medicine in rare and genetic diseases, increasing collaboration between pharma and diagnostic firms.

The rising prevalence of cancer is expected to propel the growth of the precision medicine market. Cancer remains one of the leading causes of death globally, with approximately one in five individuals developing the disease during their lifetime. Precision medicine in oncology involves analyzing tumor DNA to identify mutations or other genetic abnormalities driving cancer progression. This allows physicians to select therapies tailored to the unique genetic profile of a patient's tumor, improving treatment efficacy and outcomes. For instance, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency, over 35 million new cancer cases are projected by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Consequently, the growing incidence of cancer is driving demand for precision medicine solutions.

Major companies in the precision medicine market are emphasizing technological innovations, such as data ingestion platforms, to enhance access to public datasets and streamline analytics. Data ingestion refers to the process of collecting and importing data from multiple sources into a centralized storage or processing system. For example, in May 2023, Google Cloud, a US-based software development company, launched two AI-powered solutions designed to accelerate drug discovery and precision medicine initiatives. These tools enable researchers to interpret genomic data and identify protein structures more efficiently, improving drug development workflows, shortening time-to-market for critical therapies, and facilitating collaboration across research teams and multi-cloud environments.

In July 2024, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired Olink Proteomics for an undisclosed amount. This acquisition expands Thermo Fisher's capabilities in proteomics-the large-scale study of proteins-which plays a crucial role in precision medicine. Olink Proteomics, a Sweden-based biotechnology company, contributes innovative technologies and services focused on protein biomarker analysis, supporting targeted therapies and personalized treatment approaches.

Major companies operating in the precision medicine market are Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co. Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co. Ltd., Daewoong Pharmaceutical Co.Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, Uniao Quimica

North America was the largest region in the precision medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the precision medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The precision medicine market consists of sales of imatinib, personalized medicine, and individualized medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Precision Medicine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses precision medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for precision medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The precision medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Technology: Big Data Analytics; Bioinformatics; Gene Sequencing; Drug Discovery; Companion Diagnostics; Other Technology
2) By Application: Oncology; Respiratory Diseases; Central Nervous System Disorders; Immunology; Genetic Diseases; Other Applications.
3) By End-Use: Pharmaceutical Companies; Diagnostic Companies; Healthcare And IT Firms; Others
Subsegments:
1) By Big Data Analytics: Predictive Analytics; Prescriptive Analytics; Data Mining
2) By Bioinformatics: Genomic Data Analysis; Proteomics Data Analysis; Metabolomics Data Analysis
3) By Gene Sequencing: Next-Generation Sequencing (NGS); Sanger Sequencing; Whole Genome Sequencing
4) By Drug Discovery: Target Identification And Validation; Lead Compound Discovery; Preclinical And Clinical Trials
5) By Companion Diagnostics: Biomarker Testing; Genomic Profiling; Companion Diagnostic Tests
6) By Other Technology: Personalized Treatment Plans; Telemedicine And Digital Health Solutions; Wearable Health Technology
Companies Mentioned: Quest Diagnostics; Thermo Fisher Scientific Inc.; Roche Holding AG; Medtronic plc; Novartis AG; Pfizer Inc.; Qiagen; AstraZeneca plc.; Abbott Laboratories; Nordic Bioscience A/S; Takeda Pharmaceutical Company Ltd.; Otsuka Pharmaceutical Co. Ltd.; Daiichi Sankyo; China National Pharmaceutical Group Co. Ltd.; GE Healthcare; Randox Laboratories; Almac Group; Sun Pharma; Nichi-Iko Pharmaceutical Co. Ltd.; Daewoong Pharmaceutical Co.Ltd; GlaxoSmithKline; Teva UK Limited; Vectura Group; Merck & Co.; Boehringer Ingelheim; Mylan; Zentiva; Sanofi; Apotex; Gilead Sciences; Bayer; AbbVie Inc.; Amgen; Janssen Pharmaceutica; Accord Healthcare Inc.; Acerus Precision Medicine Corporation; AA Pharma Inc; Sanfer; LABORATORIOS SENOSIAIN SA DE CV; Siegfried Rhein; Biocrates LifeSciences; Nanostring Technologies; Tepnel Pharma Services; Intomics; Silicon Biosystems; EMS Pharma; Eurofarma; Biolab Farmaceutica; Cristalia; Uniao Quimica
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH4MPMED02_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Precision Medicine Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Precision Medicine Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Precision Medicine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Precision Medicine Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Artificial Intelligence & Autonomous Intelligence
- 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.1.5 Industry 4.0 & Intelligent Manufacturing
4.2. Major Trends
- 4.2.1 Rising Adoption Of Companion Diagnostics
- 4.2.2 Shift Toward Personalized Oncology Therapies
- 4.2.3 Integration Of Multi-Omics Data In Clinical Decision-Making
- 4.2.4 Expansion Of Precision Medicine In Rare And Genetic Diseases
- 4.2.5 Increasing Collaboration Between Pharma And Diagnostic Firms

5. Precision Medicine Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies
5.2 Diagnostic Companies
5.3 Healthcare Providers And Hospitals
5.4 Research Institutes And Academic Centers
5.5 Biotechnology Companies

6. Precision Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Precision Medicine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Precision Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Precision Medicine Market Size, Comparisons And Growth Rate Analysis
7.3. Global Precision Medicine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Precision Medicine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Precision Medicine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Precision Medicine Market Segmentation

9.1. Global Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology
9.2. Global Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications
9.3. Global Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others
9.4. Global Precision Medicine Market, Sub-Segmentation Of Big Data Analytics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Predictive Analytics, Prescriptive Analytics, Data Mining
9.5. Global Precision Medicine Market, Sub-Segmentation Of Bioinformatics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Genomic Data Analysis, Proteomics Data Analysis, Metabolomics Data Analysis
9.6. Global Precision Medicine Market, Sub-Segmentation Of Gene Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Next-Generation Sequencing (NGS), Sanger Sequencing, Whole Genome Sequencing
9.7. Global Precision Medicine Market, Sub-Segmentation Of Drug Discovery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Target Identification And Validation, Lead Compound Discovery, Preclinical And Clinical Trials
9.8. Global Precision Medicine Market, Sub-Segmentation Of Companion Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Biomarker Testing, Genomic Profiling, Companion Diagnostic Tests
9.9. Global Precision Medicine Market, Sub-Segmentation Of Other Technology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Personalized Treatment Plans, Telemedicine And Digital Health Solutions, Wearable Health Technology

10. Precision Medicine Market Regional And Country Analysis

10.1. Global Precision Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Precision Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Precision Medicine Market

11.1. Asia-Pacific Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Precision Medicine Market

12.1. China Precision Medicine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Precision Medicine Market

13.1. India Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Precision Medicine Market

14.1. Japan Precision Medicine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Precision Medicine Market

15.1. Australia Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Precision Medicine Market

16.1. Indonesia Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Precision Medicine Market

17.1. South Korea Precision Medicine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Precision Medicine Market

18.1. Taiwan Precision Medicine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Precision Medicine Market

19.1. South East Asia Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Precision Medicine Market

20.1. Western Europe Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Precision Medicine Market

21.1. UK Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Precision Medicine Market

22.1. Germany Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Precision Medicine Market

23.1. France Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Precision Medicine Market

24.1. Italy Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Precision Medicine Market

25.1. Spain Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Precision Medicine Market

26.1. Eastern Europe Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Precision Medicine Market

27.1. Russia Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Precision Medicine Market

28.1. North America Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Precision Medicine Market

29.1. USA Precision Medicine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Precision Medicine Market

30.1. Canada Precision Medicine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Precision Medicine Market

31.1. South America Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Precision Medicine Market

32.1. Brazil Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Precision Medicine Market

33.1. Middle East Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Precision Medicine Market

34.1. Africa Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Precision Medicine Market Regulatory and Investment Landscape

36. Precision Medicine Market Competitive Landscape And Company Profiles

36.1. Precision Medicine Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Precision Medicine Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Precision Medicine Market Company Profiles
- 36.3.1. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Precision Medicine Market Other Major And Innovative Companies

Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co. Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co. Ltd., Daewoong Pharmaceutical Co. Ltd.

38. Global Precision Medicine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Precision Medicine Market

40. Precision Medicine Market High Potential Countries, Segments and Strategies

40.1 Precision Medicine Market In 2030 - Countries Offering Most New Opportunities
40.2 Precision Medicine Market In 2030 - Segments Offering Most New Opportunities
40.3 Precision Medicine Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer